Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Strata Skin Sciences, Inc. (SSKN) had Revenue of $6.81M for the most recently reported fiscal quarter, ending 2025-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-03-31

Income Statement Financials
Revenue	$6.81M
Net Income	$-2.43M
Cost of Goods Sold	$3.17M
Gross Profit	$3.65M
Operating Expenses	$8.83M
Operating Income	$-2.02M
Non-Operating Income/Expense	$-0.42M
Pre-Tax Income	$-2.43M
Normalized Pre-Tax Income	$-2.43M
Income after Taxes	$-2.43M
Income from Continuous Operations	$-2.43M
Consolidated Net Income/Loss	$-2.43M
Normalized Income after Taxes	$-2.43M
EBIT	$-2.02M
EBITDA	$-0.67M
Weighted-Average Shares Outstanding (Basic)	4.17M
Weighted-Average Shares Outstanding (Diluted)	4.17M
Earnings per Share (EPS) (Basic)	$-0.58
Earnings per Share (EPS) (Diluted)	$-0.58
Balance Sheet Financials
Current Assets	$15.88M
Property, Plant, and Equipment	$9.46M
Long-Term Assets	$18.39M
Total Assets	$34.26M
Current Liabilities	$15.14M
Long-Term Debt	$15.23M
Long-Term Liabilities	$16.45M
Total Liabilities	$31.59M
Common Equity	$2.67M
Tangible Shareholders Equity	$-4.84M
Shareholders Equity	$2.67M
Common Shares Outstanding	4.17M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-0.55M
Cash Flow from Investing Activities	$-0.20M
Cash Flow from Financial Activities	--
Beginning Cash	$8.60M
End Cash	$7.85M
Increase/Decrease in Cash	$-0.75M
Stock-Based Compensation	$0.13M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.05
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.85
Debt to Equity Ratio	5.71
Gross Margin	53.54%
Operating Margin	-29.58%
EBIT Margin	-29.58%
EBITDA Margin	--
Pre-Tax Profit Margin	-35.70%
Profit Margin	-35.70%
Free Cash Flow	$-0.75M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.20
Inventory Turnover	1.19
Receiveable Turnover	1.36
Days Sales in Receivables	66.15
Return on Equity	-91.12%
Return on Tangible Equity	50.20%
Return on Assets	-7.10%
Return on Investments	-13.59%
Book Value Per Share	$0.64
Free Cash Flow per Share	$-0.18
Operating Cash Flow per Share	$-0.13

Data from Zacks Investment Research, Inc.